Purple Biotech Ltd. Sponsored ADR PPBT

1.49 0.01 0.68% as of 25 Sep
Market cap
$2.4M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments 14.66 7.44 6.68 6.40 57.81 47.20 32.11 15.41 8.52 9.57
Receivables 0.15 — 0.74 1.49 0.50 1.27 1.14 — — —
Other current assets 0.24 0.55 1.83 1.91 0.98 1.28 1.14 0.38 0.38 0.29
Total current assets 14.90 7.98 8.51 8.30 59.28 48.47 33.26 15.79 8.91 9.87
Property, Plant, Equpment (Net) 0.02 0.03 0.04 0.04 0.18 0.28 0.22 0.15 0.12 0.12
Long-Term Investments — — — — 3.07 0.19 — — — —
Goodwill and Intangible Assets (Total) — 6.17 6.17 6.17 20.48 20.48 20.68 28.04 27.84 7.36
Long-term assets (Other) — — — 0.21 3.07 0.16 — — — —
Total non-current assets 0.02 6.20 6.21 6.42 24.52 21.73 21.37 28.51 28.13 7.71
Total Assets 14.91 14.18 14.72 14.72 83.80 70.20 54.62 44.30 37.04 17.57
Accounts Payable 0.52 0.22 0.71 1.25 1.20 1.47 2.13 3.53 1.46 2.07
Other current liabilities 0.76 2.01 0.55 2.10 1.69 2.59 4.74 2.52 1.15 4.07
Total current liabilities 1.27 3.97 3.31 3.55 3.10 4.25 7.06 9.70 3.99 7.75
Pension and Post-Retirement Liabilities 0.26 0.49 0.41 0.29 0.27 0.29 0.15 0.14 0.14 0.16
Non-current Liabilities (Other) 0.26 1.03 0.40 0.28 0.27 0.29 0.15 2.52 — —
Total non-current liabilities 0.26 1.52 0.41 0.31 0.95 0.84 0.47 0.30 0.14 0.16
Total liabilities 1.53 5.50 3.72 3.86 4.05 5.09 7.52 10.01 4.13 7.91
Additional Paid In Capital 30.83 35.98 44.60 46.99 118.91 123.95 126.41 133.18 147.63 152.48
Retained Earnings (26.20) (38.47) (43.67) (49.52) (77.52) (95.90) (117.57) (137.45) (144.69) (171.08)
Shareholders Equity (Other) 8.76 9.90 9.60 12.96 38.00 36.78 38.08 38.48 29.92 28.31
Common Equity (Total) 13.39 8.69 11.00 10.86 79.75 65.11 47.10 34.30 32.91 9.66
Shareholders Equity (Total) 13.39 8.69 11.00 10.86 79.75 65.11 47.10 34.30 32.91 9.66
Shareholders Equity and Liabilities (Total) 14.91 14.18 14.72 14.72 83.80 70.20 54.62 44.30 37.04 17.57
Shares (Common) 0.00 0.01 0.01 0.01 0.09 0.09 0.09 0.13 0.26 0.93
Shareholders Equity (Tangible) 13.39 2.52 4.83 4.69 59.27 44.62 26.41 6.25 5.07 2.30
Net Debt (14.66) (7.43) (6.68) (6.39) (57.80) (47.20) (32.11) (15.41) (8.52) (9.57)
Total Debt — — — 0.22 0.90 0.75 0.52 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates